SAITOU Motoaki | Department of Obstetrics and Gynecology, Jikei University School of Medicine
スポンサーリンク
概要
- SAITOU Motoakiの詳細を見る
- 同名の論文著者
- Department of Obstetrics and Gynecology, Jikei University School of Medicineの論文著者
関連著者
-
ISONISHI Seiji
Department of Obstetrics and Gynecology, Jikei University School of Medicine, Aoto Hospital
-
Yasuda Makoto
Department Of Applied Chemistry Faculty Of Engineering Osaka University
-
Tanaka Tadao
Department Of Obstetrics And Gynecology Jikei University School Of Medicine
-
Tanaka Tadao
Department Of Environmental Safety Research Japan Atomic Energy Research Institute
-
Isonishi Seiji
Department Of Obstetrics And Gynecology Jikei University School Of Medicine Aoto Hospital
-
Isonishi Seiji
Department Of Obstetrics And Gynecology Jikei University Daisan Hospital
-
SAITOU Motoaki
Department of Obstetrics and Gynecology, Jikei University School of Medicine
-
Saitou Motoaki
Department Of Obstetrics And Gynecology Jikei University School Of Medicine
-
Yasuda Makoto
Department Of Analytical Chemistry School Of Pharmaceutical Sciences Teikyo University
-
Yasuda Makoto
Department Of Obstetrics And Gynecology Daisan Hospital
-
Fukunaga Masaharu
Department Of Pathology Jikei University School Of Medicine
-
HIRAMA Masanori
Department of Obstetrics and Gynecology, Jikei University School of Medicine, Aoto Hospital
-
Ishikawa Hiroshi
Department Of Public Health Mie University School Of Medicine
-
Hirama Masanori
Department Of Obstetrics And Gynecology Jikei University School Of Medicine Aoto Hospital
-
Kiyokawa Takako
Department Of Pathology Jikei University School Of Medicine
-
NISHII Hiroshi
Department of Obstetrics and Gynecology, Daisan Hospital
-
Nishii Hiroshi
Department Of Obstetrics And Gynecology Daisan Hospital
-
Ishikawa Hiroshi
Department Of Anatomy Jikei University School Of Medicine
-
Ishikawa Hiroshi
Department Of Anatomy Jikai University School Of Medicine
著作論文
- Small cell carcinoma of the ovary : clinical and biological study
- Primary chemotherapy-associated effect of second-line chemotherapy on survival of patients with advanced ovarian cancer